SCHEMBL7554080

SCHEMBL7554080

Cc1nc(-c2ccc(-c3ccc(C(N)=O)cc3C)cc2)no1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.55
MAPK14 Q16539 3/20 0.53
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
SMYD3 Q9H7B4 1/20 0.47
RAB9A P51151 4/20 0.47
LMNA P02545 3/20 0.47
TSHR P16473 2/20 0.47
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
HTR1D P28221 6/20 0.46
HTR1B P28222 5/20 0.46
HTR2A P28223 5/20 0.46
HPGD P15428 3/20 0.46
MEN1 O00255 3/20 0.46
MAPT P10636 3/20 0.46
KMT2A Q03164 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7445617 0.92 PLK1 (0.51) PLK1MAPK14CA12CA1CA2
Hydrochloric Acid SCHEMBL38666104 0.91 HTR1D (0.52) PLK1MAPK14CA12CA1CA2
SCHEMBL7450212 0.88 MAPK14 (0.57) PLK1MAPK14CA12CA1CA2
SCHEMBL5843831 0.85 PLK1 (0.67) PLK1MAPK14CA12CA1CA2
SCHEMBL22411177 0.85 NPC1 (0.45) PLK1MAPK14RAB9AHTR1DHTR1B
SCHEMBL8792955 0.84 PLK1 (0.65) PLK1MAPK14CA12CA1CA2
SCHEMBL5465792 0.82 PLK1 (0.52) PLK1MAPK14RAB9ALMNATSHR
SCHEMBL30509227 0.82 RAB9A (0.53) PLK1MAPK14CA12CA1CA2
SCHEMBL5316474 0.81 GAA (0.49) PLK1MAPK14RAB9AMEN1MAPT
SCHEMBL6926831 0.81 PLK1 (0.51) PLK1MAPK14RAB9ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 WO disclosed
EP-0819126-A1 BIPHENYLAMIDE DERIVATIVES AS 5HT 1D? ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1998-01-21 EP disclosed
EP-0787133-A1 TRICYCLIC SPIRO COMPOUNDS PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-08-06 EP disclosed
WO-1996031508-A1 BIPHENYLAMIDE DERIVATIVES AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-10-10 WO disclosed
EP-0733048-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-09-25 EP disclosed
WO-1995015954-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-06-15 WO disclosed